Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This publication by the World Health Organization outlines the diagnostic target product profiles for monitoring and evaluation of helminth control programs. It addresses the public health response to parasitic worm infections, which affect millions globally, particularly in tropical regions with poor sanitation. The document discusses preventive measures, including the use of anthelminthic medications, and evaluates available diagnostic tools such as the Kato-Katz technique and newer methods like qPCR. The aim is to guide efforts in reducing the prevalence of helminth infections and to improve health outcomes in affected populations. Intended for public health professionals and policymakers, it provides a framework for effective control strategies.

Helminthiasis. --- Diagnostic services. --- Helminthiasis --- Diagnostic services

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This publication by the World Health Organization (WHO) outlines the standards for universal access to rapid tuberculosis diagnostics. Aimed at healthcare professionals and policymakers, it provides a comprehensive framework to improve TB diagnostic processes globally. The book details steps for identifying TB symptoms, accessing testing, and receiving diagnoses, emphasizing the need for widespread availability and use of rapid diagnostic tests. It also discusses barriers and enablers in implementing these standards and presents strategies for scaling up diagnostic access through case studies. The document highlights WHO's coordinated efforts and collaboration with global experts to enhance TB diagnostics, thereby aiming to control and eventually eradicate tuberculosis worldwide.

Diagnostic services. --- Tuberculosis. --- Diagnostic services --- Tuberculosis

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This protocol, published by the World Health Organization in 2023, provides a comprehensive guide for the performance evaluation of rapid diagnostic tests for detecting Vibrio cholerae O1 or O19. Aimed at Performance Evaluation Laboratories and manufacturers of in vitro diagnostics, the document outlines procedures for assessing the accuracy, sensitivity, specificity, and operational ease of use of these tests in laboratory settings. It emphasizes compliance with WHO requirements and is designed to ensure suitability for use in resource-limited environments. The protocol includes detailed instructions on specimen collection, data analysis, quality control measures, and ethical considerations, making it an essential resource for those involved in the evaluation of diagnostic tools for cholera detection.

Diagnostic services. --- Cholera. --- Diagnostic services --- Cholera

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This report details the proceedings of the third meeting of the WHO Technical Advisory Subgroup on Onchocerciasis, held in Geneva from February 26 to 28, 2019. The meeting focused on evaluating diagnostic tools for onchocerciasis, including comparisons of various ELISA platforms and rapid diagnostic tests (RDTs). Discussions included elimination mapping strategies and milestones for achieving the 2030 Sustainable Development Goals related to onchocerciasis. The report serves as a resource for health professionals and policymakers engaged in the control and elimination of neglected tropical diseases, providing insights into diagnostic advancements and strategic planning for disease elimination.

Onchocerciasis --- Diagnostic services

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This publication by the World Health Organization (WHO) provides detailed profiles for diagnostic tests used in the diagnosis of mpox (monkeypox). It outlines target product profiles for these tests, aiming to guide the development and implementation of diagnostic tools in response to the mpox outbreak. The document emphasizes the need for accurate laboratory confirmation through nucleic acid amplification tests, such as PCR, to identify suspected cases efficiently. It also addresses the global health implications due to the widespread cases reported since May 2022, highlighting the urgency of effective diagnostic measures. The intended audience includes healthcare professionals, laboratory technicians, and public health officials involved in disease surveillance and outbreak management.

Monkeypox --- Diagnostic services